Search Results 1011-1020 of 18068 for multiple%20sclerosis
About this study. Study CRB-401 is a 2-part, non-randomized, open label, multi-site Phase 1 study of bb2121 in adults with relapsed/refractory multiple ...
July 20, 2022. Research. 2022 Gerstner Awardee to investigate dual CAR-T cell therapy for multiple myeloma cancer. Susan Murphy. July 20, 2022. Mobile app for ...
Read more about research in: Frontotemporal degeneration (FTD) and amyotrophic lateral sclerosis (ALS). Memory disorders. Neurodegenerative diseases.
Mayo Clinic cancer expert highlights advancements in treating multiple myeloma. Kelley Luckstein. March 20, 2023. Science Saturday: New standards and open ...
20 in the nation for research. ... MRI scanner will open new avenues of research in epilepsy, multiple sclerosis, cerebral ... Destination Medical Center continues ...
Mayo Clinic researchers to study causes of rapidly progressive dementia featured image · High blood pressure in pregnancy a risk factor for early heart disease ...
... Sclerosis Multidisciplinary Clinic: A Single-Arm Retrospective Clinical Study. ... A call for multiple system atrophy centers of excellence. ... 2017 Sep; 56 (3): ...
Displaying 11-20 out of 63 doctors available ... ysiological assessment, Limb loss, Peripheral nerve injury, Multiple sclerosis ... 20, 2024. Share on ...
Rochester, Minnesota: 20-009516. NCT ID: NCT04745884. About this study. The purposes of this study are to determine if the Braincare monitor can identify ...
Rochester, Minnesota: 20-005720; Scottsdale/Phoenix, Arizona: 20-005720; Jacksonville, Florida: 20-005720 ... Multiple Myleoma (R/R MM). Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.